Jubilant Ingrevia Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.3x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SOLARINDS Solar Industries India Limited | ₹19,240 | ₹1.7L Cr | 83.4 | 27.72 | 32.6 | 38.1 | 0.17 |
| PIDILITIND Pidilite Industries Limited | ₹1,390 | ₹1.5L Cr | 57.2 | 13.11 | 23.9 | 31 | 0.05 |
| SRF SRF Limited | ₹2,350 | ₹68K Cr | 29 | 4.55 | 14.3 | 14.6 | 0.35 |
| COROMANDEL Coromandel International Limited | ₹— | ₹51K Cr | 27.1 | 4.12 | 16.4 | 22 | 0.11 |
| LINDEINDIA Linde India Limited | ₹— | ₹49K Cr | 89.3 | 15.49 | 13.6 | 18.2 | 0.02 |
| FLUOROCHEM Gujarat Fluorochemicals Limited | ₹— | ₹47K Cr | 75.3 | 5.25 | 7.82 | 9.64 | 0.29 |
| FACT Fertilizers and Chemicals Travancore Limited | ₹— | ₹43K Cr | 2,930 | 41 | 1.61 | 8.65 | 2.79 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
JUBLINGREA · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% |
| FII | 6.35% | 6.58% | 6.55% | 7.22% | 6.89% | 7.12% |
| DII | 11.17% | 13.60% | 14.07% | 15.47% | 15.99% | 15.91% |
| Public | 30.17% | 27.53% | 27.10% | 25.09% | 24.90% | 24.76% |
| Others | 0.82% | 0.81% | 0.81% | 0.77% | 0.74% | 0.73% |
Corporate Events
To consider and approve the financial results for the period ended September 30, 2026
Dividend - Rs 2.50 Per Share
To consider and approve the financial results for the period ended Jun 30, 2026
Interim Dividend - Rs 2.50 Per Share
Dividend - Rs 2.50 Per Share
Interim Dividend - Rs 2.50 Per Share
Dividend - Rs 2.50 Per Share
Interim Dividend - Rs 2.50 Per Share
Dividend - Rs 2.50 Per Share
Latest News
All newsJubilant Ingrevia announces change in management
*Jubilant Ingrevia announces change in management*. The company has filed a regulatory update regarding a shift in its management structure. While no financial details were disclosed, such changes can influence investor sentiment and operational direction. The impact hinges on the roles and profiles of incoming and outgoing executives. 📊 *STOCKS:* $JUBLINGVA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #ManagementChange
Jubilant Ingrevia announces board meeting outcomes.
*Jubilant Ingrevia announces board meeting outcomes.* The company disclosed outcomes from its October 27, 2026 board meeting. No major financials or strategic moves were detailed in the filing. Further updates expected in subsequent disclosures. 📊 *STOCKS:* $JUBLING | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting
Jubilant Ingrevia to release Q2 and H1 FY27 results
*Jubilant Ingrevia to release Q2 and H1 FY27 results.* The company will present its financial and operational performance for the quarter and half year ended September 30, 2026. Traders will focus on revenue growth, margin trends, and guidance. Key metrics include **Q2 revenue**, **EBITDA margin**, and **net profit**. 📊 *STOCKS:* JUBLINGREA | 🏢 *SECTOR:* Chemicals | #MEDIUMIMPACT #Earnings
Jubilant Ingrevia shares unchanged after investor presentation.
*Jubilant Ingrevia shares showed no significant movement following its investor presentation.* The presentation detailed the company’s business operations and strategic outlook without any **major financial announcements** or surprises. Traders await upcoming quarterly results for clearer direction. 📊 *STOCKS:* $JUBLING | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateUpdate
Jubilant Ingrevia announces general updates under Scheme 2021
*Jubilant Ingrevia announces general updates under Scheme 2021.* The company filed a disclosure regarding ongoing corporate restructuring activities under the approved scheme. No financial figures or major operational changes were disclosed. The update appears procedural in nature. 📊 *STOCKS:* $JUBLINGREA | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateUpdate
Jubilant Ingrevia announces updates on wholly-owned subsidiary
*Jubilant Ingrevia announces updates on wholly-owned subsidiary.* The company filed general corporate updates with the NSE regarding its subsidiary structure. No financial figures or strategic changes were disclosed. The move appears to be a routine compliance or administrative update. 📊 *STOCKS:* $JUBLINGVA | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #Corporate
Jubilant Ingrevia to mature commercial paper on record date
*Jubilant Ingrevia to mature commercial paper on record date*. The company has announced the record date for the maturity of its commercial paper. This is a routine update on short-term debt obligations. No financial impact is expected beyond existing liabilities. 📊 *STOCKS:* $JUBLINGREAL | 🏢 *SECTOR:* FMCG | #LOWIMPACT #Funding
Jubilant Ingrevia publishes mandatory newspaper notice.
*Jubilant Ingrevia publishes mandatory newspaper notice.* This is a routine regulatory disclosure as per corporate filing norms. No **financial** or **operational** impact is indicated. Such publications are standard practice for listed companies. 📊 *STOCKS:* $JUBLINGREAL | 🏢 *SECTOR:* Food Processing | #LOWIMPACT #CorporateFiling
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.2K Cr 12.2% | ₹1.1K Cr 6.2% | ₹1.1K Cr 8.0% | ₹1.0K Cr 1.2% | ₹1.1K Cr 0.6% | ₹1.1K Cr 1.1% | ₹1.0K Cr 2.1% | ₹1.0K Cr |
| Op. Profit | ₹163 Cr 29.4% | ₹126 Cr 6.7% | ₹135 Cr 4.9% | ₹142 Cr 3.4% | ₹147 Cr 6.5% | ₹138 Cr 11.3% | ₹124 Cr 12.7% | ₹110 Cr |
| OPM | 14.0% 16.7% | 12.0% 0.0% | 12.0% 14.3% | 14.0% 0.0% | 14.0% 7.7% | 13.0% 8.3% | 12.0% 9.1% | 11.0% |
| Net Profit | ₹86 Cr 83.0% | ₹47 Cr 31.9% | ₹69 Cr 8.0% | ₹75 Cr 1.4% | ₹74 Cr 7.2% | ₹69 Cr 16.9% | ₹59 Cr 20.4% | ₹49 Cr |
| EPS (₹) | 5.43 84.7% | 2.94 32.6% | 4.36 7.4% | 4.71 1.3% | 4.65 6.7% | 4.36 17.8% | 3.7 20.9% | 3.06 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹4.4K Cr 5.0% | ₹4.2K Cr 1.0% | ₹4.1K Cr 13.3% | ₹4.8K Cr 3.6% | ₹4.9K Cr 623.5% | ₹684 Cr | ₹0 Cr |
| Expenses | ₹3.8K Cr 4.4% | ₹3.7K Cr 1.3% | ₹3.7K Cr 12.2% | ₹4.2K Cr 2.8% | ₹4.1K Cr 624.5% | ₹567 Cr | ₹0 Cr |
| Op. Profit | ₹568 Cr 9.4% | ₹519 Cr 21.5% | ₹427 Cr 22.2% | ₹549 Cr 34.7% | ₹841 Cr 618.8% | ₹117 Cr | ₹0 Cr |
| OPM | 13.0% 8.3% | 12.0% 20.0% | 10.0% 9.1% | 11.0% 35.3% | 17.0% 0.0% | 17.0% | — |
| Other Income | ₹27 Cr 28.9% | ₹38 Cr 31.0% | ₹29 Cr 9.4% | ₹32 Cr 45.5% | ₹22 Cr 320.0% | ₹-10 Cr | ₹0 Cr |
| Interest | ₹49 Cr 12.5% | ₹56 Cr 5.7% | ₹53 Cr 140.9% | ₹22 Cr 29.0% | ₹31 Cr 342.9% | ₹7 Cr | ₹0 Cr |
| Depreciation | ₹175 Cr 10.8% | ₹158 Cr 16.2% | ₹136 Cr 11.5% | ₹122 Cr 0.8% | ₹123 Cr 459.1% | ₹22 Cr | ₹0 Cr |
| PBT | ₹370 Cr 7.6% | ₹344 Cr 28.4% | ₹268 Cr 38.7% | ₹437 Cr 38.4% | ₹709 Cr 820.8% | ₹77 Cr | ₹0 Cr |
| Tax % | 25.0% 7.4% | 27.0% 15.6% | 32.0% 6.7% | 30.0% 9.1% | 33.0% 10.0% | 30.0% | 0.0% |
| Net Profit | ₹278 Cr 10.8% | ₹251 Cr 37.2% | ₹183 Cr 40.6% | ₹308 Cr 35.4% | ₹477 Cr 783.3% | ₹54 Cr | ₹0 Cr |
| EPS (₹) | 17.45 10.7% | 15.77 37.4% | 11.48 40.5% | 19.31 35.5% | 29.93 777.7% | 3.41 200.3% | -3.4 |
| Div Payout | 28.0% 9.7% | 31.0% 27.9% | 43.0% 65.4% | 26.0% 52.9% | 17.0% 70.0% | 10.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
Liabilities | |||||||
| Equity Capital | ₹16 Cr 0.0% | ₹16 Cr 0.0% | ₹16 Cr 0.0% | ₹16 Cr 0.0% | ₹16 Cr 0.0% | ₹16 Cr 31900.0% | ₹0.05 Cr |
| Reserves | ₹3.1K Cr 6.8% | ₹2.9K Cr 6.9% | ₹2.7K Cr 2.7% | ₹2.6K Cr 9.6% | ₹2.4K Cr 26.7% | ₹1.9K Cr | ₹0 Cr |
| Borrowings | ₹792 Cr 3.7% | ₹764 Cr 3.2% | ₹740 Cr 81.8% | ₹407 Cr 71.0% | ₹238 Cr 57.2% | ₹556 Cr | ₹0 Cr |
| Other Liabilities | ₹1.6K Cr 17.1% | ₹1.3K Cr 6.7% | ₹1.2K Cr 5.5% | ₹1.2K Cr 5.9% | ₹1.1K Cr 25.1% | ₹888 Cr | ₹0 Cr |
| Total Liabilities | ₹5.5K Cr 9.1% | ₹5.0K Cr 6.3% | ₹4.7K Cr 11.1% | ₹4.2K Cr 12.3% | ₹3.8K Cr 12.4% | ₹3.4K Cr | ₹0 Cr |
Assets | |||||||
| Fixed Assets | ₹3.2K Cr 23.3% | ₹2.6K Cr 1.7% | ₹2.5K Cr 37.5% | ₹1.8K Cr 2.7% | ₹1.8K Cr 0.4% | ₹1.8K Cr | ₹0 Cr |
| CWIP | ₹154 Cr 70.7% | ₹525 Cr 58.6% | ₹331 Cr 37.0% | ₹525 Cr 201.7% | ₹174 Cr 167.7% | ₹65 Cr | ₹0 Cr |
| Investments | ₹33 Cr 10.8% | ₹37 Cr 146.7% | ₹15 Cr 87.5% | ₹8 Cr 33.3% | ₹6 Cr 88.0% | ₹50 Cr | ₹0 Cr |
| Other Assets | ₹2.1K Cr 12.1% | ₹1.9K Cr 2.1% | ₹1.8K Cr 1.9% | ₹1.9K Cr 3.7% | ₹1.8K Cr 24.8% | ₹1.4K Cr | ₹0 Cr |
| Total Assets | ₹5.5K Cr 9.1% | ₹5.0K Cr 6.3% | ₹4.7K Cr 11.1% | ₹4.2K Cr 12.3% | ₹3.8K Cr 12.4% | ₹3.4K Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹524 Cr 3.1% | ₹508 Cr 18.1% | ₹430 Cr 6.9% | ₹462 Cr 2.0% | ₹453 Cr 304.5% | ₹112 Cr | ₹0 Cr |
| Investing CF | ₹-250 Cr 35.7% | ₹-389 Cr 31.5% | ₹-568 Cr 21.1% | ₹-469 Cr 560.6% | ₹-71 Cr 315.2% | ₹33 Cr | ₹0 Cr |
| Financing CF | ₹-155 Cr 20.2% | ₹-129 Cr 189.6% | ₹144 Cr 242.9% | ₹42 Cr 110.0% | ₹-418 Cr 480.6% | ₹-72 Cr | ₹0 Cr |
| Net Cash Flow | ₹119 Cr 1422.2% | ₹-9 Cr 250.0% | ₹6 Cr 82.9% | ₹35 Cr 197.2% | ₹-36 Cr 149.3% | ₹73 Cr | ₹0 Cr |
| Free Cash Flow | ₹235 Cr 50.6% | ₹156 Cr 214.7% | ₹-136 Cr 750.0% | ₹-16 Cr 107.1% | ₹225 Cr 164.7% | ₹85 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 65d 22.6% | 53d 6.0% | 50d 28.2% | 39d 9.3% | 43d 82.9% | 251d | — |
| Inventory Days | 140d 14.1% | 163d 1.9% | 160d 9.6% | 146d 24.8% | 117d 80.5% | 601d | — |
| Days Payable | 150d 6.4% | 141d 7.6% | 131d 15.9% | 113d 9.7% | 103d 85.0% | 685d | — |
| Cash Conv. Cycle | 55d 26.7% | 75d 6.3% | 80d 11.1% | 72d 26.3% | 57d 65.9% | 167d | — |
| Working Capital Days | 22d 24.1% | 29d 21.6% | 37d 11.9% | 42d 14.3% | 49d 77.7% | 220d | — |
| ROCE | 11.0% 0.0% | 11.0% 10.0% | 10.0% 37.5% | 16.0% 44.8% | 29.0% 262.5% | 8.0% | — |
Source: Screener.in · Lower days = better efficiency
About Jubilant Ingrevia Limited
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
ChemicalsChemicals & Petrochemicals